메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
저널정보
연세대학교 의과대학 Yonsei Medical Journal Yonsei Medical Journal 제60권 제1호
발행연도
2019.1
수록면
10 - 21 (12page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Antineutrophil cytoplasmic antibody-associated vasculitis (AAV) is a group of systemic necrotising vasculitides, which often involvesmall vessels, and which lead to few or no immune deposits in affected organs. According to clinical manifestations andpathological features, AAV is classified into three variants: microscopic polyangiitis, granulomatosis with polyangiitis (GPA), andeosinophilic GPA. The American College of Rheumatology 1990 criteria contributed to the classification of AAV, although currentlythe algorithm suggested by the European Medicines Agency in 2007 and the Chapel Hill Consensus Conference Nomenclatureof Vasculitides proposed in 2012 have encouraged physicians to classify AAV patients properly. So far, there have been noticeableadvancements in studies on the pathophysiology of AAV and the classification criteria for AAV in Western countries. However, studies analysing clinical features of Korean patients with AAV have only been conducted and reported since 2000. Oneyear-, 5 year-, and 10 year-cumulative patient survival rates are reported as 96.1, 94.8, and 92.8%. Furthermore, initial vasculitisactivity, prognostic factor score, age and specific organ-involvement have been found to be associated with either all-cause mortalityor poor disease course. The rate of serious infection is 28.6%, and 1 year-, 5 year- and 10 year-cumulative hospitalised infectionfree survival rates range from 85.1% to 72.7%. The overall standardised incidence ratio of cancer in AAV patients was deemed1.43 compared to the general Korean population.

목차

등록된 정보가 없습니다.

참고문헌 (108)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0